BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25557594)

  • 1. WGS and targetted sequencing in acute lymphoblastic leukemia identifies putative enhancer mutation associated with over-expression of a growth factor.
    Chenevix-Trench G
    Hum Mutat; 2015 Jan; 36(1):v. PubMed ID: 25557594
    [No Abstract]   [Full Text] [Related]  

  • 2. The mutational landscape in pediatric acute lymphoblastic leukemia deciphered by whole genome sequencing.
    Lindqvist CM; Nordlund J; Ekman D; Johansson A; Moghadam BT; Raine A; Övernäs E; Dahlberg J; Wahlberg P; Henriksson N; Abrahamsson J; Frost BM; Grandér D; Heyman M; Larsson R; Palle J; Söderhäll S; Forestier E; Lönnerholm G; Syvänen AC; Berglund EC
    Hum Mutat; 2015 Jan; 36(1):118-28. PubMed ID: 25355294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia.
    Hidaka H; Yagasaki H; Takahashi Y; Hama A; Nishio N; Tanaka M; Yoshida N; Villalobos IB; Wang Y; Xu Y; Horibe K; Chen S; Kadomatsu K; Kojima S
    Leuk Res; 2007 Aug; 31(8):1045-51. PubMed ID: 17267033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic drivers of vulnerability and resistance in relapsed acute lymphoblastic leukemia.
    Lu SX; Abdel-Wahab O
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11071-11073. PubMed ID: 27663730
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.
    Soverini S; De Benedittis C; Papayannidis C; Polakova KM; Venturi C; Russo D; Bresciani P; Iurlo A; Mancini M; Vitale A; Chiaretti S; Foà R; Abruzzese E; Sorà F; Kohlmann A; Haferlach T; Baccarani M; Cavo M; Martinelli G
    Leukemia; 2016 Jul; 30(7):1615-9. PubMed ID: 26867670
    [No Abstract]   [Full Text] [Related]  

  • 6. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.
    Robinson HM; Broadfield ZJ; Cheung KL; Harewood L; Harris RL; Jalali GR; Martineau M; Moorman AV; Taylor KE; Richards S; Mitchell C; Harrison CJ
    Leukemia; 2003 Nov; 17(11):2249-50. PubMed ID: 14523475
    [No Abstract]   [Full Text] [Related]  

  • 7. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia.
    Raynaud S; Mauvieux L; Cayuela JM; Bastard C; Bilhou-Nabera C; Debuire B; Bories D; Boucheix C; Charrin C; Fière D; Gabert J
    Leukemia; 1996 Sep; 10(9):1529-30. PubMed ID: 8751475
    [No Abstract]   [Full Text] [Related]  

  • 8. wt1 gene expression in childhood acute leukemias.
    Ozgen U; Anak S; Ozbek U; Sarper N; Eryilmaz E; Ağaoğlu L; Devecioğlu O; Yalman N; Gedikoğlu G
    Acta Haematol; 2000; 103(4):229-30. PubMed ID: 11014901
    [No Abstract]   [Full Text] [Related]  

  • 9. Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.
    Feng J; Li Y; Jia Y; Fang Q; Gong X; Dong X; Ru K; Li Q; Zhao X; Liu K; Wang M; Tian Z; Jia Y; Wang Y; Lin D; Wei H; Tang K; Mi Y; Wang J
    J Hematol Oncol; 2017 Feb; 10(1):61. PubMed ID: 28245838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome.
    Baldus CD; Martus P; Burmeister T; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK
    J Clin Oncol; 2007 Aug; 25(24):3739-45. PubMed ID: 17646667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients.
    Soverini S; De Benedittis C; Polakova KM; Linhartova J; Castagnetti F; Gugliotta G; Papayannidis C; Mancini M; Klamova H; Salvucci M; Crugnola M; Iurlo A; Albano F; Russo D; Rosti G; Cavo M; Baccarani M; Martinelli G
    Oncotarget; 2016 Apr; 7(16):21982-90. PubMed ID: 26980736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities.
    van der Linden MH; Boer JM; Schneider P; Willekes M; Seslija L; De Lorenzo P; Valsecchi MG; Cazzaniga G; Biondi A; den Boer ML; Pieters R; Stam RW
    Haematologica; 2016 Mar; 101(3):e95-8. PubMed ID: 26681762
    [No Abstract]   [Full Text] [Related]  

  • 13. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
    Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
    Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.
    Peyrouze P; Guihard S; Grardel N; Berthon C; Pottier N; Pigneux A; Cahn JY; Béné MC; Lhéritier V; Delabesse E; Macintyre E; Thomas X; Dombret H; Ifrah N; Cheok M
    Br J Haematol; 2012 Dec; 159(5):599-602. PubMed ID: 23016962
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic variation and the risk of acute lymphoblastic leukemia.
    Mullighan CG
    Leuk Res; 2010 Oct; 34(10):1269-70. PubMed ID: 20538337
    [No Abstract]   [Full Text] [Related]  

  • 16. Aplastic anemia preceding acute lymphoblastic leukemia in an adult with FAT1 mutation.
    Zhou H; Xiao M; Zhou X; Hao Y; Xin C; Tang Y; Liang Y; Zhang Y; Li S
    Minerva Med; 2019 Dec; 110(6):593-594. PubMed ID: 30843606
    [No Abstract]   [Full Text] [Related]  

  • 17. AML1 gene over-expression in childhood acute lymphoblastic leukemia.
    Mikhail FM; Serry KA; Hatem N; Mourad ZI; Farawela HM; El Kaffash DM; Coignet L; Nucifora G
    Leukemia; 2002 Apr; 16(4):658-68. PubMed ID: 11960347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of ETV6/AML1 fusion in adult acute lymphoblastic leukemia.
    Cuneo A; Agostini P; Vitale A; Foà R; Castoldi G
    Leukemia; 2003 Feb; 17(2):476-7; author reply 477. PubMed ID: 12592356
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.
    Sanchez R; Ayala R; Alonso RA; Martínez MP; Ribera J; García O; Sanchez-Pina J; Mercadal S; Montesinos P; Martino R; Barba P; González-Campos J; Barrios M; Lavilla E; Gil C; Bernal T; Escoda L; Abella E; Amigo ML; Moreno MJ; Bravo P; Guàrdia R; Hernández-Rivas JM; García-Guiñón A; Piernas S; Ribera JM; Martínez-López J
    Ann Hematol; 2017 Jul; 96(7):1069-1075. PubMed ID: 28451802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.